World Aids Day
The global challenge of HIV/AIDS remains one of the most pressing public health issues today. According to the latest data from UNAIDS, around 38.4 million people worldwide are living with HIV/AIDS, underlining the need for not only medical intervention but also comprehensive awareness, education, and social change. Despite the significant strides made in treatment and prevention, the confusion surrounding the relationship between HIV and AIDS still persists.
Young people have become influential advocates in the fight against HIV/AIDS. Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities. These young activists utilize digital platforms and peer-to-peer education to dispel myths, promote safe practices, and foster supportive environments for those affected by HIV/AIDS.
Dr Gowri Kulkarni, an expert in Internal Medicine, explains that while the terms HIV and AIDS are often used interchangeably, they are distinctly different. "HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, whereas AIDS (Acquired Immunodeficiency Syndrome) is a condition that occurs when HIV severely damages the immune system," she clarifies. To understand the implications of these differences, it's important to explore the fundamental distinctions between the two.
HIV is the virus responsible for attacking the body’s immune system, specifically targeting CD4 cells, which are crucial for the body’s defense against infections. As HIV progresses, it destroys these cells, weakening the immune system over time. If left untreated, this continuous damage can lead to AIDS.
AIDS, on the other hand, is a syndrome, not a virus. Dr Kulkarni further elaborates that AIDS is a collection of symptoms and illnesses that emerge when the immune system is severely compromised due to prolonged HIV infection. It represents the most advanced stage of HIV, and is characterized by very low CD4 counts or the onset of opportunistic infections like tuberculosis, pneumonia, or certain cancers.
A key distinction to remember is that not everyone with HIV will progress to AIDS. Thanks to advancements in medicine, particularly antiretroviral therapy (ART), individuals living with HIV can manage the virus and maintain a healthy immune system for many years, or even decades, without ever developing AIDS. ART works by suppressing the virus to undetectable levels, effectively preventing the damage HIV would otherwise cause to the immune system.
Without treatment, however, HIV progresses through three stages:
- Acute HIV Infection: This stage occurs shortly after transmission and may include symptoms like fever, fatigue, and swollen lymph nodes.
- Chronic HIV Infection: Often asymptomatic or mildly symptomatic, the virus continues to damage the immune system but at a slower rate.
- AIDS: This is the final stage, marked by severe immune damage and the presence of infections that take advantage of the compromised immune defenses.
Another key distinction between HIV and AIDS is the way in which they are transmitted. HIV is highly contagious and can be transmitted through the exchange of bodily fluids such as blood, semen, vaginal fluids, and breast milk. It is primarily spread through unprotected sexual contact, sharing needles, or from mother to child during childbirth or breastfeeding.
AIDS, however, is not transmissible. It is not a disease that can be passed from one person to another. Rather, AIDS is the result of untreated, advanced HIV infection and is a direct consequence of the virus’s damage to the immune system.
HIV and AIDS are diagnosed through different methods. HIV is diagnosed through blood tests or oral swabs that detect the presence of the virus or antibodies produced by the immune system in response to the virus. Early detection of HIV is crucial, as it allows for timely intervention and treatment, which can prevent the virus from progressing to AIDS.
AIDS, on the other hand, is diagnosed using more specific criteria. Dr Kulkarni notes that the diagnosis of AIDS is made when the individual’s CD4 cell count falls below 200 cells/mm³, or when opportunistic infections or certain cancers (such as Kaposi's sarcoma or lymphoma) are detected. Diagnosing AIDS involves a more thorough assessment of the individual’s immune function and overall health, as opposed to just the detection of HIV.
The treatment goals for HIV and AIDS differ significantly, although both involve antiretroviral therapy (ART). For HIV, the primary treatment goal is to suppress the virus to undetectable levels, thus maintaining a strong immune system and preventing further transmission of the virus. People living with HIV can often live long, healthy lives if they adhere to ART.
For individuals diagnosed with AIDS, the treatment plan becomes more complex. While ART remains an essential part of managing the virus, treatment for AIDS also focuses on addressing the opportunistic infections and secondary health complications associated with severe immune suppression. The goal of treatment for AIDS is not only to manage the HIV virus but also to improve the quality of life and extend survival by treating these secondary health issues.
While the medical community has made great strides in managing HIV, the battle to curb its transmission is also a social and cultural issue. Dr Daman Ahuja, a public health expert, highlights that HIV/AIDS awareness and education are vital to reducing transmission rates and supporting those affected by the virus. "Young people, especially, have become key advocates in the fight against HIV/AIDS," says Dr Ahuja. "Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities."
Additionally, grassroots activism plays a significant role in raising awareness and addressing stigma. As the World Health Organization reports, community-based interventions have been proven to increase HIV testing rates and improve treatment adherence, which are crucial in the fight against the pandemic.
The ultimate goal of organizations like UNAIDS is to eliminate the HIV/AIDS pandemic by 2030. Achieving this requires global collaboration, from medical treatment advancements to public health strategies, education, and advocacy. Dr Kulkarni’s insight underscores the importance of early detection, treatment adherence, and community support in the fight against HIV/AIDS.
Dr Gowri Kulkarni is Head of Medical Operations at MediBuddy and Dr Daman Ahuja, a public health expert and has been associated with Red Ribbon Express Project of NACO between 2007-12.
Credit: Times Network
The Times Network India Health Summit 2026 brought together policymakers, clinicians, researchers and healthcare industry leaders to discuss the future of India's healthcare system, with conversations spanning medical innovation, access to treatment, mental health, women's health and preventive care.
The third edition of the Times Network India Health Summit & Awards was held in New Delhi on October 28 under the theme, The Blueprint for a Future-Ready Healthcare Ecosystem: Innovation. Access. Self-Reliance.
From the use of artificial intelligence (AI) in diagnostics to advances in fertility treatment and the need to strengthen public health infrastructure, various sessions explored several aspects of how healthcare delivery could evolve. Here are the key discussions and takeaways from the summit.
Union Minister of State for Health and Family Welfare Anupriya Patel addressed the summit on building a future-ready healthcare ecosystem. With around 500 Ayushman Bharat cards issued, Patel also said that 132.5 million people had received free treatment under the scheme.
She also addressed India's Viksit Bharat 2047 vision, stating that Union health budget increased from around Rs 37,000 crore in 2014 to more than Rs 1.06 lakh crore.
Delhi Health Minister Pankaj Singh answered key questions about the city’s looming air pollution crisis. He said that the government's various pollution-control measures, including electric vehicle (EV) policy can help fight it. He also spoke about the need for long-term solutions.
Union Minister of State (Independent Charge) AYUSH Prataprao Jadhav, Madhya Pradesh Minister of State Narendra Shivaji Patel and Uttarakhand Cabinet Minister Subodh Uniyal, were also scheduled to address different aspects of healthcare policy and delivery.
Padma Bhushan Dr Shiv Kumar Sarin, leading hepatologist, gastroenterologist, and medical educator who also serves as the Senior Professor, Chancellor, and Director of the Institute of Liver and Biliary Sciences (ILBS), recently spoke about the dos and don’ts to maintain a healthy liver at the Times Health Summit 2026.
From ideal breakfast time to late night eating, the expert spoke about common lifestyle mistakes people make that could worsen their liver health.
The session From Tradition to Therapeutics: The New Science of AYUSH was based on the role of traditional medicine in India's healthcare landscape.
Dr Biswaroop Roy Chowdhury, Founder of BRC Clinics Health, and Dr Tanmay Goswami, Founder of Goswal, discussed Ayurveda, its potential applications and questions surrounding its integration with modern medicine.
The speakers spoke about Ayurveda’s scientific research, evidence, AYUSH funding, clinical applications and integration with western medicine. The experts said that Ayurveda sector is valued at approximately $17–18 billion, while China's traditional medicine sector is estimated at around $30 billion, calling for greater investment in the sector.
Mental healthcare was another focus, with Dr Deepak Kumar, Professor and Head of the Department of Psychiatry at the Institute of Human Behaviour and Allied Sciences (IHBAS), discussing The Next Frontier in Indian Psychiatry: Specialization, Geriatric Mental Health, and De-addiction Strategies.
The doctor discussed immediate threat of suicidal thoughts, warning behavioural signs, screen addiction and need for parents to supervise and limit screen use in children.
Women's health was featured prominently at the summit, with the knowledge session Take Charge Together: Shaping a Future of Greater Breast Cancer Awareness and Better Outcomes.
The session featured Dr Meenu Walia, Chairman of Medical Oncology at Max Healthcare; Vaishali Iyer, Country Head of Communications, Patient Advocacy and CSR at Novartis in India; and Dr Pankaj Goyal, Senior Consultant and Unit Head of Medical Oncology at Rajiv Gandhi Cancer Institute.
The experts focused on the risk of recurrence, the emotional toll of breast cancer treatment, financial and societal hardships, body image issues, intimacy problems and other challenges patients face after leaving the hospital.
The panel The Fertility Revolution: Reimagining Parenthood in Modern India spoke about the evolving field of reproductive medicine and the challenges faced by people seeking fertility treatment.
The speakers included Dr Ranjana Sharma, Senior Consultant in Obstetrics and Gynaecology at Indraprastha Apollo Hospital; Dr Vimal Grover, Senior Director of Obstetrics and Gynaecology at Fortis LaFemme; Dr Hrishikesh Pai, Founder and Managing Director of Bloom IVF India; and Dr Abha Majumdar, Emeritus Consultant in IVF and Human Reproduction at Sir Ganga Ram Hospital.
The session brought attention to fertility preservation, IVF costs, male infertility, stigma women face, and the judgments that come with seeking IVF for starting a family.
The session From Silence to Care: Why India Can No Longer Ignore Menopause focused on menopause and the need to bring greater attention to women's health during midlife.
The session was led by Sanjith Shetty, Founder and CEO of Miror. He spoke about the suicide rates among menopausal women, along with other life challenges like divorces, retirements, and social isolation.
The fireside chat From LifeSpan to HealthSpan: Can Science Help Us Live Longer and Better? explored the science of longevity and the difference between living longer and maintaining good health for more years.
The conversation featured Dr Chirantan Bose and Dr Preetesh Bhandari, founders of Vytalyou. They spoke about the importance of maintaining muscle health, monitoring neurological health, and warding off lifestyle diseases like obesity and diabetes.
The role of technology in modern medicine was explored in Precision Diagnostics: AI, Genomics & The New Era Of Personalized Care. The panel featured Dr Arjun Dang, CEO and Partner at Dr Dangs Lab; Dr Manish Vaish, Director and Head of the Institute of Neurosciences at Medanta, Noida; and Dr Belal Bin Asaf, Director of the Institute of Chest Surgery, Chest Onco-Surgery and Lung Transplant at Medanta, Noida.
The discussion focused on the evolving role of artificial intelligence and genomics in diagnostics, personalised treatment and improving diagnostic accuracy.
The future of specialised medical services was examined in The Next Frontier of Advanced Care: Scaling Capacity, Innovation & Clinical Excellence. The session brought together Dr V.S. Chauhan, Chairman and Managing Director of Prakash Hospitals and Institutions, and Prof. Dr Sanjeev Bagai, Chairman of Nephron Clinic.
The discussion centred on expanding advanced healthcare capacity, strengthening clinical excellence and leveraging innovation and technology to improve patient outcomes while making specialised treatment more accessible.
Addressing the challenges of equitable healthcare delivery, Reengineering Public Health Infrastructure: Last-Mile Delivery, Digital Health Equity, and Rural Access brought together Dr Anoop Saraya of the Institute of Liver & Biliary Sciences; Dr Charu Dutt Arora of AmeriHealth Home Healthcare, Asian Institute of Medical Sciences; Dr Gyanendra Kumar of Maulana Azad Institute of Dental Sciences; Girish Krishnamurthy, CEO of Tata Medical & Diagnostics; and Dr Jyoti Wadhwa of Apollo Athenaa Women's Cancer Centres.
The session focused on strengthening public health infrastructure, improving rural and last-mile access, and exploring the role of digital health and healthcare delivery models in bridging gaps in access to medical services.
Credit: Times Network
The journey of a breast cancer patient does not end when their treatment comes to a conclusion. There is always a risk of recurrence, which makes regular follow-ups and adherence to treatment important.
At the Times Network India Health Summit and Awards 2026 in New Delhi, a panel formed by Dr Priya Parmar, Chief Operating Officer, Indian Cancer Society, Delhi, Dr. Jyoti Wadhwa - Principal Lead of Medical and Precision Oncology, Apollo Athena Women’s Cancer Centres, New Delhi and Apollo Hospital, Gurgaon, Dr. Meenu Walia, Chairman Medical Oncology, Max Healthcare, Dr Pankaj Goyal, Sr Consultant and Unit Head, Medical Oncology, RGCI, and Vaishali Iyer, Country Head, Communications, Patient Advocacy and CSR, Novartis in India, discussed the big picture after breast cancer treatment.
During a panel discussion titled “Take Charge Together: Shaping a Future of Greater Breast Cancer Awareness and Better Outcomes,” experts highlighted the physical, emotional, social and financial challenges that women may continue to face after treatment among many more.
For many women, the period after breast cancer can involve more than medical monitoring. They may face fatigue, menopausal symptoms and changes in body image after undergoing a major physical change, while concerns about intimacy, fertility and relationships can affect emotional and mental well-being.
Dr. Priya Parmar highlighted how losing a breast or hair can affect a woman's sense of identity and femininity. Some survivors also face social stigma related to marriage and fertility, while sexual health and relationship concerns may remain difficult to discuss.
The burden can be greater for women who lack family support or have limited financial resources. These circumstances may affect not only emotional recovery but also their ability to attend follow-up appointments and continue treatment.
The financial strain can become particularly difficult if cancer returns and further investigations or treatment are required.
Dr. Meenu Walia said that treatment for advanced disease can add to the economic burden faced by patients and their families.
Also read: Vanessa Trump Recovers From 'Very Invasive' Breast Cancer, Reveals Early Sign Of The Disease
The risk of breast cancer recurrence is not the same for every patient. It depends on the cancer's stage and subtype, tumour grade, lymph node involvement, response to treatment and whether treatment is timely.
Dr. Jyoti Wadhwa explained that different breast cancer subtypes can follow different recurrence patterns.
Triple-negative breast cancer tends to recur earlier, often within the first two to three years after treatment. Hormone receptor-positive, HER2-negative breast cancer, however, can return even 10 to 20 years later.
She also said that patients who achieve a pathological complete response after treatment given before surgery may have a lower risk of recurrence than those with residual disease.
However, a lower estimated risk does not mean the risk is eliminated. Continued monitoring is important even for patients who have responded well to treatment.
Also read: Beyond the Lump: Overlooked Breast Cancer Symptoms That Can Delay Diagnosis
One concern raised by the experts was that some patients stop taking prescribed oral hormone therapy or miss appointments after their symptoms improve.
“Your first attempt at treatment is always your best attempt,” Dr. Walia said, underlining the importance of appropriate diagnosis and treatment from the outset.
Follow-up care helps doctors monitor a patient's recovery, assess treatment-related effects and make decisions based on individual clinical circumstances. The appropriate schedule and any further treatment depend on the patient's diagnosis, risk profile and medical history.
Experts also cautioned against allowing the possibility of recurrence to dominate a survivor's life. Understanding individual risk should help patients make informed decisions, rather than leave them in constant fear that cancer will return.
The long-term effects of breast cancer also have implications beyond the individual patient. Vaishali Iyer, Country Head of Communications, Patient Advocacy and CSR at Novartis in India, highlighted an estimated 140 million productive hours lost due to breast cancer care, drawing attention to its wider economic impact.
Dr. Wadhwa emphasised the need to address treatment-related concerns, including menopausal symptoms and bone health, which may require attention even after primary cancer treatment has ended.
Dr. Pankaj Goyal, Senior Consultant and Unit Head of Medical Oncology at RGCI, stressed that doctors must build trust with patients and explain recurrence risks without causing unnecessary alarm. Discussions about care should also account for patients' personal circumstances and financial constraints.
The panel discussion, titled “Take Charge Together: Shaping a Future of Greater Breast Cancer Awareness and Better Outcomes,” took place at the Times Network India Health Summit and Awards 2026.
Credit: Times Health Summit 2026
Padma Bhushan Dr Shiv Kumar Sarin, leading hepatologist, gastroenterologist, and medical educator who also serves as the Senior Professor, Chancellor, and Director of the Institute of Liver and Biliary Sciences (ILBS), recently spoke about the dos and don’ts to maintain a healthy liver at the Times Health Summit 2026.
Held under the theme “The Blueprint for a Future-Ready Healthcare Ecosystem – Innovation. Access. Self-Reliance,” the summit brought together healthcare professionals and industry stakeholders to discuss innovation, access to treatment and policy approaches shaping India's healthcare sector.
The doctor addressed the daily morning ritual of drinking hot water in the morning, which a lot of people follow to release bowels.
Dr Sarin said, “Don't use hot water or anything for that matter to make you go to the toilet because it is the connection between the brain and the bowel that is very important.
He also spoke about opting for other drinks like coconut water or lemon water with honey. He said that lemon can help improve iron absorption in your body.
He added, “As per coconut water is concerned, it has potassium which is very good for your bowel health but it should still not be an everyday thing. For nimbu and honey, you should remember that honey has fructose. So if you are consuming honey, you also need to churn that out."
Also read: Fatty Liver Disease: Scientists Identify 5 Subtypes With Different Health Risks
Many of us do not know what is the right time for breakfast. It is especially important as eating after fasting for eight to ten hours affects your energy and metabolic health throughout the day.
Dr Sarin said, "It's after sunrise. Minimum 12 hours after the last food that you have eaten. Ussay pehle galti nahi kariyega khaanay ki. Let the stomach, and the bacteria and the intestine recover."
He also spoke about whether you should have fruits for breakfast. "Breakfast should be fruits. And, low calories fruits. Avoid carbs."
There is a lot of information as well as misinformation about coffee consumption and liver health. Dr S K Sarin spoke in its favour and said that it could prevent a lot of liver conditions.
He said, "It does many things. it clears several toxic things including fat, clears the flow of bile, good enzyme inducer, prevents fibrosis of the liver and can decrease cirrhosis and also the development of liver cancer."
He also warned ignoring healthy dietary habits and simply relying on coffee is also not ideal. He added, "Coffee is not medicine, it is something which can help you prevent and not treat."
Dr Sarin also warned against eating more amount carbohydrates than the recommended limit. He explained how sitting next to an obese person can make you feel physically lethargic as their breath may emit endogenous alcohol.
When you eat a carbohydrate-heavy meal, your digestive system breaks down carbohydrates into sugars. Certain microorganisms in the gut, including yeasts and some bacteria, can ferment these sugars and produce small amounts of ethanol, or alcohol. This is known as endogenous alcohol production.
Dr Sarin recommends eating low-carb meals for lunch like sprouts, vegetables, yoghurt, buttermilk or low-sugar fruits.
Dr Sarin recommends having dinner before sunset. He also said that having late-night dinners could disrupt your sleep.
He added, "Obesity during youth increases the risk of heart disease later in life. After the age of 40, eating one meal a day may have health implications. The total daily calorie intake should not exceed 300–400. Avoid eating late at night. Eating late can also affect your insulin resistance."
Dr Sarin also said that thin people can also have unhealthy fat that may cause fatty liver. He recommended yearly screens to keep liver health in check.
He said, "Even thin people can have excess body fat and low muscle mass, which may affect their health. Being thin does not necessarily mean being healthy. Maintaining good muscle mass is important."
© $2026 Times Horizon Private Limited